Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Aetna is the first major insurer to waive copays for Narcan. Photo: John Minchillo / AP
Aetna will waive copays for Narcan, a medication that reverses opioid overdoses, starting Jan. 1. Narcan copays could be as much as $150 for some Aetna enrollees, but the company said $30 to $40 has been a more common range.
Why it matters: Health insurers have been spotlighted as enabling the opioid epidemic and now are focusing on ways to prevent or manage addiction. The other major national health insurers — Anthem, Cigna, Humana and UnitedHealthcare — did not immediately respond when asked whether they would copy Aetna's policy.